FIELD: medicine.
SUBSTANCE: phenibut is prescribed as a neuroimmune disorder corrector in immunopathological conditions. Phenibut is introduced to CBA mice and white nonlinear rats in single dose 12.5-100 mg/kg intraperitoneally or in dose 25 mg/kg orally in therapeutic course 14 days.
EFFECT: method allows avoiding or reducing a risk of negative effects with underlying observed immunological imbalance.
11 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OBTAINING IMMUNOTROPIC PREPARATION AS BASE FOR MEDICATION "IMMUNOFLAN" | 2011 |
|
RU2491949C2 |
| METHOD OF CORRECTING DISORDERS OF IMMUNE AND PSYCHOEMOTIONAL STATUS OF ORGANISM IN EXPERIMENTAL INFORMATION STRESS | 2010 |
|
RU2432949C1 |
| METHOD OF MODELLING IMMUNODEFICIENT STATE BY NEUTROPHIL GRANULOCYTE SYSTEM | 1995 |
|
RU2118850C1 |
| ANTIDEPRESSANT, ANXIOLYTIC, NEUROPROTECTIVE AND IMMUNOSTIMULATING AGENT | 2010 |
|
RU2429834C1 |
| METHOD OF CORRECTION OF IMMUNE SYSTEM OF LIVING BODY | 2000 |
|
RU2167659C1 |
| MEDICATION, WHICH POSSESES IMMUNOSTIMULATING ACTIVITY | 2009 |
|
RU2403054C1 |
| METHOD OF PREPARING NUCLEOPROTEID COMPLEXES FROM BIRD EMBRYOS SHOWING IMMUNOTROPIC AND RADIOPROTECTIVE ACTIVITY | 1995 |
|
RU2110267C1 |
| EXTRACT FOR TREATMENT OF PERIODONTUM DISEASES | 2004 |
|
RU2275206C2 |
| MEDICATION POSSESSING IMMUNOTROPIC ACTIVITY | 2009 |
|
RU2406524C1 |
| MODULATOR OF BRAIN ACTIVITY IN AGE-RELATED MAMMALS | 2021 |
|
RU2758010C1 |
